Actinium Pharmaceuticals Inc (ATNM)
8.73
-0.17
(-1.91%)
USD |
NYAM |
May 10, 16:00
8.73
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Price: 8.73 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 10, 2024 | 8.91 | 9.00 | 8.40 | 8.73 | 196174.0 |
May 09, 2024 | 8.68 | 8.970 | 8.54 | 8.90 | 224438.0 |
May 08, 2024 | 8.75 | 8.75 | 8.36 | 8.71 | 157700.0 |
May 07, 2024 | 8.88 | 8.94 | 8.45 | 8.81 | 227055.0 |
May 06, 2024 | 9.00 | 9.00 | 8.35 | 8.84 | 288175.0 |
May 03, 2024 | 8.95 | 9.20 | 8.54 | 8.96 | 528663.0 |
May 02, 2024 | 7.95 | 8.81 | 7.91 | 8.75 | 682893.0 |
May 01, 2024 | 7.68 | 7.96 | 7.605 | 7.78 | 227262.0 |
Apr 30, 2024 | 7.31 | 7.979 | 7.31 | 7.70 | 282660.0 |
Apr 29, 2024 | 6.90 | 7.48 | 6.88 | 7.38 | 244844.0 |
Apr 26, 2024 | 6.58 | 6.92 | 6.485 | 6.87 | 206378.0 |
Apr 25, 2024 | 6.96 | 6.97 | 6.47 | 6.56 | 328850.0 |
Apr 24, 2024 | 6.93 | 7.32 | 6.881 | 7.06 | 153433.0 |
Apr 23, 2024 | 7.03 | 7.43 | 6.85 | 6.96 | 185256.0 |
Apr 22, 2024 | 6.92 | 7.34 | 6.82 | 7.17 | 192609.0 |
Apr 19, 2024 | 6.64 | 7.01 | 6.60 | 6.85 | 347635.0 |
Apr 18, 2024 | 7.26 | 7.512 | 6.66 | 6.67 | 420871.0 |
Apr 17, 2024 | 7.73 | 7.817 | 7.20 | 7.25 | 297442.0 |
Apr 16, 2024 | 8.45 | 8.45 | 7.65 | 7.74 | 373923.0 |
Apr 15, 2024 | 8.95 | 9.10 | 8.28 | 8.44 | 255522.0 |
Apr 12, 2024 | 8.97 | 9.04 | 8.55 | 9.00 | 303644.0 |
Apr 11, 2024 | 9.02 | 9.28 | 9.00 | 9.09 | 461385.0 |
Apr 10, 2024 | 8.79 | 9.15 | 8.72 | 8.99 | 344890.0 |
Apr 09, 2024 | 9.12 | 9.13 | 8.70 | 8.98 | 343856.0 |
Apr 08, 2024 | 9.50 | 9.68 | 8.87 | 9.13 | 432190.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.02
Minimum
Nov 28 2023
18.00
Maximum
Aug 03 2020
7.706
Average
7.386
Median
Mar 10 2020
Price Benchmarks
Perspective Therapeutics Inc | 1.75 |
Eli Lilly and Co | 760.00 |
Cellectar Biosciences Inc | 3.07 |
Outlook Therapeutics Inc | 7.58 |
Bristol-Myers Squibb Co | 44.94 |
Price Related Metrics
PEG Ratio | -0.1421 |
Price to Book Value | 5.929 |
Earnings Yield | -19.59% |
Market Cap | 260.01M |
PEGY Ratio | -0.1421 |